Clients “are ‘very impressed’ by Chad Rolston.”Chambers US 2015

Chad G. Rolston

Silicon Valley
  • 140 Scott Drive
  • Menlo Park, CA 94025
  • USA

Chad Rolston advises private and public companies and private equity firms and their portfolio companies on strategic transactions, including: acquisitions, dispositions, carve-outs, joint ventures, controlling and minority investments, growth equity, as well as general corporate matters.

Mr. Rolston regularly advises clients across a range of industries, including:

  • Software
  • Semiconductors
  • Internet and digital media
  • Healthcare and life sciences
  • Retail and consumer products

Drawing on prior software sales and engineering experience and complementary experience representing both strategic and financial buyers and sellers in public and private M&A, he has a keen sense of the needs and interests of parties on all sides of a deal. He also advises on significant cross-border transactions with market-leading companies.

Mr. Rolston’s public and private mergers and acquisitions and strategic transaction practice has included advising numerous companies, including:

  • Hippo Enterprises, a provider of home insurance products, in its US$5 billion business combination with Reinvent Technology Partners Z
  • Silver Lake, a global leader in technology investing, in its:
    • US$750 million investment in Jio Platforms
    • Strategic investment in TEG
  • Broadcom Limited (formerly Avago Technologies) in its:
    • US$37 billion acquisition of Broadcom Corporation
    • US$6.6 billion acquisition of LSI Corporation
    • US$606 million acquisition of Emulex Corporation
  • Mellanox Technologies in its:
    • US$811 million acquisition of EZchip Semiconductor
    • US$82 million acquisition of Kotura
    • US$48 million acquisition of IPtronics
  • Pericom Semiconductor in its US$413 million sale to Diodes and successful defense against hostile bidder Montage Technology
  • Mattson Technology in its US$300 million sale to Beijing E-Town Capital
  • Relypsa in its sale to Galenica for US$1.53 billion
  • Alios BioPharma in its sale to Johnson & Johnson for US$1.75 billion
  • DVS Sciences in its sale to Fluidigm Corp. for US$207.5 million
  • Thoratec Corporation in its acquisition of assets from Terumo Corporation for US$56.5 million
  • Transcept Pharmaceuticals in its reverse merger with Paratek Pharmaceuticals
  • Kimpton Hotels in its sale to the Intercontinental Group for US$430 million
  • Lucasfilm in its sale to The Walt Disney Company for US$4.05 billion
  • OpenTable in its sale to The Priceline Group for US$2.6 billion
  • Intuit in its:
    • Sale of its Quicken business to H.I.G. Capital
    • US$7.1 billion acquisition of Credit Karma
  • Modernizing Medicine in its acquisition of gMed, Inc.
  • AlphaDraft in its sale to FanDuel
  • Quantum Analytics in its sale to Black Forest Ventures

Mr. Rolston has robust experience representing private equity clients in their acquisitions and dispositions. While at a previous law firm, he worked with numerous private equity clients, including Vista Equity Partners, Golden Gate Capital, Gryphon Investors, and Swander Pace Capital. Following are select deals he has handled while at Latham:

  • Bridgepoint Advisers, in its acquisition with Summit Partners of Calypso Technology, a provider of financial market software solutions
  • PWP Growth Equity, a private equity fund managed by Perella Weinberg Partners, in connection with acquisition and investment transactions
  • Encore Consumer Capital in its sale of Juice Tyme to Highlander Partners
  • Indigo Partners in its acquisition of Frontier Airlines
  • PRA International, a Genstar Capital portfolio company, in its acquisition of ClinStar
  • Technology Crossover Ventures in the sale of XRS Corporation to a portfolio company of Vista Equity Partners
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.